1. Home
  2. EHAB vs XOMA Comparison

EHAB vs XOMA Comparison

Compare EHAB & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EHAB
  • XOMA
  • Stock Information
  • Founded
  • EHAB 2014
  • XOMA 1981
  • Country
  • EHAB United States
  • XOMA United States
  • Employees
  • EHAB N/A
  • XOMA N/A
  • Industry
  • EHAB Hospital/Nursing Management
  • XOMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • EHAB Health Care
  • XOMA Health Care
  • Exchange
  • EHAB Nasdaq
  • XOMA Nasdaq
  • Market Cap
  • EHAB 409.1M
  • XOMA 457.6M
  • IPO Year
  • EHAB N/A
  • XOMA N/A
  • Fundamental
  • Price
  • EHAB $7.70
  • XOMA $36.74
  • Analyst Decision
  • EHAB Buy
  • XOMA Strong Buy
  • Analyst Count
  • EHAB 3
  • XOMA 2
  • Target Price
  • EHAB $8.67
  • XOMA $69.50
  • AVG Volume (30 Days)
  • EHAB 376.2K
  • XOMA 51.9K
  • Earning Date
  • EHAB 11-05-2025
  • XOMA 11-06-2025
  • Dividend Yield
  • EHAB N/A
  • XOMA N/A
  • EPS Growth
  • EHAB N/A
  • XOMA N/A
  • EPS
  • EHAB N/A
  • XOMA N/A
  • Revenue
  • EHAB $1,037,800,000.00
  • XOMA $44,952,000.00
  • Revenue This Year
  • EHAB $4.95
  • XOMA $88.91
  • Revenue Next Year
  • EHAB $4.33
  • XOMA $13.80
  • P/E Ratio
  • EHAB N/A
  • XOMA N/A
  • Revenue Growth
  • EHAB N/A
  • XOMA 194.98
  • 52 Week Low
  • EHAB $6.47
  • XOMA $18.35
  • 52 Week High
  • EHAB $10.91
  • XOMA $38.34
  • Technical
  • Relative Strength Index (RSI)
  • EHAB 47.88
  • XOMA 66.37
  • Support Level
  • EHAB $7.53
  • XOMA $33.59
  • Resistance Level
  • EHAB $8.16
  • XOMA $38.34
  • Average True Range (ATR)
  • EHAB 0.23
  • XOMA 1.64
  • MACD
  • EHAB -0.04
  • XOMA -0.03
  • Stochastic Oscillator
  • EHAB 26.98
  • XOMA 74.72

About EHAB Enhabit Inc.

Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: